1. Mert GG, Incecik F, Altunbasak S, Herguner O, Mert MK, Kiris N, Unal I. Factors affecting epilepsy development and epilepsy prognosis in cerebral palsy. Pediatr Neurol 2011; 45: 89-94.
2. İncecik F, Hergüner MÖ, Mert G, Alabaz D, Altunbaşak Ş. Acute cerebellar ataxia associated with enteric fever in a child: a case report. Turk J Pediatr 2013; 55:441-2
3. İncecik F, Hergüner MÖ, Yıldızdaş D, Yılmaz M, Mert G, Horoz ÖO, Altunbaşak Ş. Posterior reversible encephalopathy syndrome due to pulse methylprednisolone therapy in a child. Turk J Pediatr 2013; 55: 455-7.
4. Mert GG, İncecik F, Günaşti S, Hergüner MÖ, Altunbaşak Ş. Psoriasiform drug eruption associated with sodium valproate. Case Reports in Pediatrics 2013;1-3
5. Incecik F, Hergüner MO, Mert G, Erdem S, Altunbaşak S. Ring chromosome 14 syndrome presenting with intractable epilepsy: a case report. Turk J Pediatr 2013; 55:549-51.
6. Gul Mert G, Horoz OO, Herguner MO, Incecik F, Yildizdas RD, Onenli Mungan N, Yuksel B, Altunbasak S. Hashimoto's encephalopathy: four cases and review of literature. Int J Neurosci 2014 ;124:302-6.
7. Incecik F, Herguner OM, Altunbasak S, Mert G, Kiris N. Risk of recurrence after discontinuation of antiepileptic drug therapy in children with epilepsy. J Pediatr Neurosci 2014; 9:100-4.
8. İncecik F, Hergüner MÖ, Mert G, Önenli-Mungan N, Ceylaner S, Kör D, Altunbaşak Ş. X-linked adrenoleukodystrophy in a 6-year-old boy initially presenting with psychiatric symptoms. Turk J Pediatr 2014;56: 651-3.
9. Incecik F, Altunbasak S, Herguner OM, Mert G, Sahan D. Prognostic significance of failure of the initial antiepileptic drug in children with benign childhood epilepsy with centrotemporal spikes. Brain Dev 2014; 37: 66-70.
10. Yilmaz BS, Kor D, Ceylaner S, Mert GG, Incecik F, Kartal E, Mungan NO. Two novel missense mutations in nonketotic hyperglycinemia. J Child Neurol 2015; 30: 789-92.
11. Coşkun-Benlidayı İ, Başaran S, Gül-Mert G, Güzel R. Early rehabilitation of a child with intensive care unit acquired weakness secondary to membranoproliferative glomerulonephritis: A case report. Turk J Pediatr 2015; 57: 422-5.
12. Gül-Mert G, İncecik F, Hergüner MÖ, Ceylaner S, Altunbaşak Ş. Pyridoxine-dependent epilepsy in two Turkish patients in Turkey and review of the literature. Turk J Pediatr 2015; 57: 394-7.
13. Çelik T, Çelik Ü, Tolunay O, Kömür M, Başpınar H, Yılmaz C, Mert G, Yıldızdaş D. Epstein-Barr virus encephalitis with substantia nigra involvement. J Pediatr Neurosci 2015; 10: 401-3.
14. Gul Mert G, Herguner MÖ, Incecik F, Altunbasak S, Sahan D, Unal I. Risk factors affecting prognosis in infantile spasm. Int J Neurosci 2017; 11: 1012-8.
15. İncecik F, Hergüner MÖ, Özbek M, Yılmaz M, Rizzo WB, Gül Mert G. Neuro-ichthyotic syndromes: A case series. Journal of Pediatric Neurosciences 2018; 13: 34-38.
16. Bulut FD, Kör D, Şeker Yılmaz B, Gül Mert G, Kılavuz S, Önenli Mungan N. Turkish case of ethylmalonic encephalopathy misdiagnosed as short chain acyl-CoA dehydrogenase deficiency. Metabolic Brain Disease 2018; 33: 977-9.
17. Gül Mert G, Altunbaşak Ş, Hergüner ÖM, İncecik F, Cansever Övetti H, Özcan N, Kuşçu D, Ünal İ. Factors affecting epilepsy prognosis in patients with tuberous sclerosis. Child’s Nervous System 2019; 35: 463-8.
18. Gül Mert G, Koç Uçar H. The effect of neuroradiological findings on cognitive functions in patients with neurofibromatosis type 1. Cukurova Medical Journal 2019; 44, 1-7
19. Gül Mert G, Özcan N, Hergüner Ö, Altunbaşak Ş, İncecik F, Bişgin A, Ceylaner S. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients. Acta Neurol Belg 2019; DOI: 10.1007/s13760-019-01246-9
20. Aslan Nagehan, Yıldızdaş D, Coban Y, Horoz Özgür Ö, Gül Mert G, Özcan N. A Novel Adverse Event of Nusinersen Treatment: Thrombocytosis. The Indian Journal of Pediatrics 2019; 86: 1157
21. Aslan Nagehan, Yıldızdaş D, Huseyinli B, Horoz Özgür Ö, Gül Mert G, Ekinci F, Ozcanyüz D. Levetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent. J Pediatr Intensive Care 2020; 2: 139-140